NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Novo A/S’

30 June 2015

Spinifex investors to exit as Novartis agrees to $200m-plus buyout

health healthcare drugs pills medication medical Novo A/S, Canaan Partners, GBS Venture Partners, Brandon Capital Partners, Uniseed and the University of Queensland will shortly exit their investments in Spinifex Pharmaceuticals, as Novartis International AG has agreed to buy it for $200m cash, "plus undisclosed clinical development and regulatory milestone payments".

14 May 2014

Ceterix Orthopaedics venture backers re-up through $18m financing

Bone Therapeutics A trio of venture capital firms have renewed their commitment to surgical tool maker Ceterix Orthopaedics through an $18m financing round.

2 May 2013

Danish biopharma Symphogen secures €141m from existing investors

Danish biopharmaceutical company Symphogen has closed an expansion of its previously announced €100m financing, securing a €141m placement of preferred stock to a group of existing investors.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015